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ABSTRACT 
There are numerous proteins that are found capable of forming beta sheet-rich 
aggregates called as amyloid aggregates. Amyloid- like aggregates is seen in wide 
range of diseases such as Alzheimer’s disease, Parkinson’s disease, Prion disease and 
diabetes etc. Amyloid aggregates of prion diseases have the distinction of being 
infectious.  
Astonishingly, a single polypeptide of a prion protein can fold into different amyloid 
conformations which differ in structural features and yield faithfully propagating prion 
strains or variants that manifest as different symptoms of the disease. One key question, 
therefore, is whether the ability to form variants is limited to a prion protein or a 
general property of all amyloids. In this regard, it was investigated here whether the 
amyloid forming protein hen egg white lysozyme (HEWL) could form amyloid 
variants. Indeed we have found that by altering the fibrillization conditions, it is 
possible to obtain HEWL amyloid variants. These findings could have implications in 
understanding of the human lysozyme amyloidosis disease affecting kidney which is 
found to be associated with different hereditary mutation in lysozyme in different 
subjects. Furthermore, the findings here support that amyloid variant formation may be 
a generic property of amyloid forming proteins. 
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1.1. INTRODUCTION  
The name ‘amyloid’ was coined initially by Rudolph Virchow in 1954. The deposits 
found in kidney liver and spleen of diseases patients were given the name amyloid 
based on the color reaction with iodine and sulphuric acid similar to starch (amylum) 
[1]. But now we know that those deposits called amyloids are actually beta sheet rich 
protein aggregates and many proteins have the inherent property of forming amyloid-
like aggregates [2]. 
Interest in studying amyloid fibrils stems from their participation in different 
fields such as their role in diseases [3, 4], role as an alternative structural state for many 
peptides and proteins [5]. Almost all polypeptides can form amyloid under appropriate 
conditions and the process of such conversion has become a central question in protein 
biochemistry [3]. Amyloids can also be used as basis for nanomaterials with possible 
applications [6]. 
 Amyloids are associated with number of diseases such as Alzheimers, Parkinsons 
and prion diseases. Moreover it is also found that few amyloids have a particular role in 
normal biology. These amyloids are termed as functional amyloids [3, 7]. Structural 
studies on amyloid were initially done by investigating the X-ray diffraction patterns 
[8]. It was concluded that there are elongated peptide chains arranged parallel to each 
other but perpendicular to the axis of the aggregate (amyloid finer). This is referred as 
cross-beta structural pattern [9] (Figure 1.1). 
 
Figure 1.1 (a) Cross beta diffraction pattern as observed when focused by X-rays. 
(David Eisenberg, et al. Cell, 2012, [4]). (b) Cross-beta sheet structure of the segment 
GNNQQNY from yeast prion protein Sup35 with central fibril axis. (Nelson R, et al. 
Nature, 2005, [10]). 
B 
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1.2. AMYLOID  
Amyloid is an abnormal protein, insoluble in nature, fibrous, cross beta sheet 
containing extracellular proteinaceous deposit found in tissues and organs in vivo [11]. 
 The route of amyloid formation involves partial unfolding of polypeptides chains 
resulting in a conformation which enables the polypeptide chains to interact with each 
other and organize into an ordered structure called amyloid fibrils. These are beta sheet 
rich protein deposits; they show cross beta diffraction pattern. The beta sheets run 
parallel to the fiber axis with individual beta strands perpendicular to the fiber axis [10]. 
Amyloids exhibit a phenomenon known as seeding i.e. the rate of formation of fibrils 
by amyloidogenic protein increases by the addition of preformed fibrils [12]. Amyloids 
are long, unbranched, filamentous, insoluble, and protease resistant fibrils. Their 
diameter varies from 80-100 A° and length from 1000-16000 A° (Figure 1.2).  
  
Figure 1.2: Electron micrographic view of amyloid fibrils 
Asparagine and glutamine are commonly found in amyloid structures, they bind to dyes 
like thioflavin T resulting in enhanced fluorescence and Congo red resulting in apple 
green birefringence. These features differentiate the amyloid fibrils from other fibril 
like structures such as silk fibroin and collagen. Amyloids also exhibit partial stability 
against denaturants like Guanidine Hydrochloride (GdnHCl) and non-specific proteases 
like proteinase K. Different proteins can be deposited extracellular as amyloid in 
various locations of human body. 
 The growth of amyloid occurs mostly via nucleation dependent polymerization process 
(Figure 1.3). It shows a sigmoidal growth curve which includes three phases: Lag 
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phase, log phase and stationary phase. In the presence of nucleus from preformed 
fibrils the amyloid growth occurs fast with reduced lag phase and the phenomenon is 
called seeding. Seeding can be done for same proteins called self-seeding. Seeding is 
also possible in closely related proteins sharing sequence similarity called cross-
seeding. The seeding phenomenon is one of the important features of amyloid exhibited 
by almost all amyloid fibrils.  
 
  Figure 1.3: Nucleus formation and polymerization of amyloid fibrils [13]. 
With the understanding of amyloid structure, it has been found that single polypeptide 
can fold into different amyloid conformations as in case of prions [14, 15]. In this 
thesis, conformational variants of amyloid formed from a globular protein, lysozyme 
has been characterized. The protein was fibrillized in vitro under different physiological 
conditions and then assessed for the conformational variants. 
1.3. AMYLOIDOSIS 
Amyloidosis is a class of diseases associated with the deposition of abnormally folded 
proteins in the form of amyloid fibrils. In few cases called Familial or primary 
amyloidosis, amyloid fibrils result due to the presence of abnormal protein. The major 
cause of amyloid deposits associated with disease in vivo is the point mutation in the 
amino acid sequence which destabilizes the protein. In other cases called senile 
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amyloidosis, amyloid deposits occur due to abnormally high quantity of protein or due 
to its presence for many years [1]. The amyloid deposits restricted to a particular organ 
lead to localized amyloidosis, example: Aβ amyloidosis (Alzheimer disease) and 
amyloid deposits affecting many different organ systems lead to systemic amyloidosis, 
example: AL amyloidosis (immunoglobulin light chain) [16]. The modern classification 
of amyloid protein was decided at the Second International Symposium on 
Amyloidosis, Helsinki (1974). Some of the amyloid diseases and their respective 
amyloid proteins are listed below in the table 1.1. 
Table 1.1: Amyloid diseases and their precursor proteins [5] 
S. No. Amyloid Diseases Amyloid protein 
1 Alzheimer's disease Amyloid β peptides 
2 Parkinson's disease α-synuclein 
3 Huntington's disease Huntingtin 
4 Primary systemic amyloidosis 
Immunoglobulin light and 
heavy chains 
5 Atherosclerosis Apolipoprotein AI 
6 Atrial amyloidosis Atrial natriuretic factor 
7 Rheumatoid arthritis Serum amyloid A 
8 Familial amyloid polyneuropathy Transthyretin 
9 
Hereditary non-neuropathic systemic 
amyloidosis 
Lysozyme 
10 Dialysis related amyloidosis β-2 microglobulin 
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1.4. PRIONS 
Prion  diseases  or  transmissible  spongiform  encephalopathies  are neurodegenerative 
disorders  seen  in  both  humans  and  animals.  The causative agents are believed to be 
prion proteins. Prions are infectious protein, similar to virus but lack nucleic acid. They 
can propagate in misfolded state and can induce other properly folded proteins to 
misfold leading to amyloid plaque formation and neurodegeneration [17]. Prions are 
ordered cross-beta aggregates similar to amyloids. Several studies on prion structure, 
their transmission, mechanism of formation has been done using yeast models and yeast 
prion proteins. The normal prion protein PrP
c 
is converted to infectious conformational 
isoform PrP
SC
 in mammals [18]. They are called infectious since they can convert other 
PrP
c 
molecules to misfolded PrP
SC
 form. Several studies have shown that yeast contains 
proteins either in soluble form or in infectious amyloid form. Protein in soluble and 
infectious form shows different phenotype. Prion aggregates mostly results in “loss of 
function phenotype”, example: Sup35 is translational termination factor in yeast which 
when converts to prion form results in less efficient translational termination. Not only 
loss of function prion forms can also result in “gain of new function”. Example: 
[PIN+], prion forms of Rnq1enhances the formation of another prion de novo.  
 Not only prions amyloids have also been hypothesized to form “functional 
amyloid”. This hypothesis states that organisms have evolved to take advantage of such 
prion amyloid forms [7, 19]. Table 1.2 below has enlisted few examples of functional 
amyloids. 
In yeast each prion protein has been shown to form different infectious aggregates 
associated with different phenotype and different conformation. These are referred to as 
“prion variants”. The rising number of prions and amyloid proteins reflects that they 
may have biological role.  
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Table 1.2: List of functional amyloids in different organisms 
Organism Protein Function 
Bacteria – E. coli Curli  
Help to create a proteinaceous matrix that 
enables surface adhesion and colony 
formation  
Fungi – Saccharomyces 
cerevisiae 
Ure2p Regulates nitrogen metabolism 
Fungi – Podospora 
anserina 
HET-s Regulates heterokaryon formation 
Homo sapiens  Pmel17 Role in biosynthesis of the pigment melanin 
 
1.5. VARIANTS OF PRIONS 
Prion variants or strains can be defined as amyloids with different conformations of a 
single protein sequence and thus resulting in different phenotypes in vivo. All these 
variants can propagate successfully. For example, in yeast Sup35 protein results in 
[PSI+] prion protein. This [PSI+] prion forms different conformations of Sup35 [20-
22]. Infections with these conformations lead to different prion strains. This finding 
solved a major question of how a protein- only infectious agent causes disease with 
different phenotypes in genetically identical animals. This kind of conformational 
variants can also be observed in amyloid aggregates. 
So far, only few cases have been observed and Aβ11-25 amyloid is the best example. 
Different conformations of Aβ amyloid have been observed at different polymerizing 
conditions. 
a) Aβ fibers form antiparallel structure at pH 7.4 as well as pH 2.4 but it was found that β-
strand register was 17+k ⇔ 20−k at pH 7.4, and the register changed to 17+k ⇔ 22−k 
at pH 2.4 where k represents integer values, and the two numbers are the residue 
numbers of adjacent positions on neighboring β-strands [23]. 
 
 
16 
 
 
Figure 1.4: Different conformations of Aβ amyloid formed at different pH 
Figure 1.4 shows the conformational variants formed at different pH conditions due to 
difference in secondary structure packing. 
b)  Full  length  Aβ1-40   peptide  formed  different  amyloid  structures  under  still  and  
stirring conditions. Agitated fibers displayed two-fold symmetry i.e. two Aβ1–40 units 
per β-strand width, whereas the static fibers showed three-fold symmetry i.e. three 
Aβ1–40 units per β-strand width [24]. 
 
 
Figure 1.5: Two fold and three fold symmetry of amyloid formed from Aβ1-40 fragment 
 
 
 
 
 
Two fold symmetry 
  
  
Three fold symmetry  
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1.6. HEN EGG WHITE LYSOZYME: A MODEL AMYLOID 
Here, we studied amyloid of the protein Hen Egg White Lysozyme (HEWL), which 
shares 60% sequence identity with human lysozyme. Natural variants of human 
lysozyme are known to form amyloid plaques in vivo resulting in familial non-
neuropathic systemic amyloidosis. The protein lysozyme was discovered by Flemming 
in 1922. Since then lysozyme has served as a good model protein for investigations on 
protein structure and function. A wealth of information is available on the structural 
details and folding of both human and HEW lysozyme. Lysozyme has been isolated in 
human tears, saliva and mother's milk, as well as viruses, bacteria, phage, plants, 
insects, birds, reptiles and other mammalian fluids. It has a molecular weight of 14307 
Da and is synthesized by hepatocytes, polymorphs and macrophages. It hydrolyzes β 
(1-4) linkages between N-acetylmuraminic acid and N-acetyl-D-glucosamine residues 
in peptidoglycan [25, 26].  
 HEWL forms amyloid fibrils in vitro under acidic conditions (pH 2.0, glycine HCl 
buffer) at 37 °C similar to the pathogenic fibrils of human lysozyme in physiological 
environment. Several other conditions have been developed for the fibrillization of hen 
egg white lysozyme which includes (a) incubation at elevated temperatures (60 °C) and 
low pH, 2.0, (b) incubating soluble lysozyme in concentrated solution of ethanol, (c) 
SDS (at very low concentrations) has also been found to induce amyloid formation 
from hen egg lysozyme (d) moderate concentrations of guanidine hydrochloride is also 
shown to induce amyloid formation from hen egg lysozyme (e) alkaline pH at room 
temperature. 
Structure: It has two structural domains, an alpha domain composed of alpha helices 
and a beta domain composed of triple stranded antiparallel beta sheet and a 310 helix 
near C-terminal. 310 helices are slightly shorter in length than α-helices at 
approximately three residues per turn. The active site has two catalytic residues i.e. 
glutamate-35 and aspartate-52. A cleft formed near active site allows the binding of 
substrates i.e. bacterial cell wall components. 
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It has four disulphide bonds between cysteine residues 6:127, 30:115, 64:80, and 76:94 
which act to stabilize the structure. 
  
Figure 1.6: Structure of HEWL, PDB ID: 1HEW 
Hen egg white lysozyme sequence (129 amino acids): 
KVFGRCELAA AMKRHGLDNY RGYSLGNWVC AAKFESNFNT 
QATNRNTDGS TDYGILQINS RWWCNDGRTP GSRNLCNIPC SALLSSDITA 
SVNCAKKIVS DGNGMNAWVA WRNRCKGTDV QAWIRGCRL 
Human lysozyme sequence (130 amino acids): 
KVFERCELAR TLKRLGMDGY RGISLANWMC LAKWESGYNT 
RATNYNAGDR STDYGIFQIN SRYWCNDGKT PGAVNACHLS CSALLQDNIA 
DAVACAKRVV RDPQGIRAWV AWRNRCQNRD VRQYVQGCGV 
1.7. LYSOZYME AMYLOIDOSIS 
Human lysozyme is known to form amyloid fibrils similar to the pathogenic ones. 
Natural variants of human lysozyme are known to form amyloid plaques in vivo 
resulting in so called familial non-neuropathic systemic amyloidosis. The two common 
natural substitution mutations are Ile56Thr and Asp67His which cause autosomal 
dominant hereditary amyloidosis [27, 28]. The mutants are shown to be enzymatically 
active. Human lysozyme can cause growth of large quantities of amyloid in liver, 
kidney, and other regions of gastrointestinal tract leading to non-neuropathic systemic 
amyloidosis. Lysozyme amyloid mainly results in renal amyloidosis [29, 30]. Several 
studies have begun to find out the mechanism of how lysozyme aggregate in vivo. 
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Understanding the mechanism may help to come up with therapeutic implications for 
the treatment of lysozyme amyloidosis.  
 
Table 1.3: List of mutations in human lysozyme leading to lysozyme amyloidosis  
Mutation Reported phenotype 
Tyr54Asn GI tract involvement Sicca syndrome 
Ile56Thr Renal failure, Petechiae 
Phe57Ile Renal failure 
Trp64Arg Renal failure, GI tract involvement Sicca syndrome, 
Spontaneous hepatic hemorrhage 
Asp67His Renal failure,GI tract involvement, Liver, Spleen,Sicca 
syndrome 
Asp67Gly Renal failure, Sicca syndrome 
Trp112Arg GI tract involvement, Liver, Spleen, Renal failure 
 
From previous case reports it has been found that lysozyme amyloidosis results in 
recurrent hepatic hematoma [31]. Lysozyme amyloidosis has also been observed in 
association with sarcoidosis [32]. Other case reports show the renal manifestation with 
sicca syndrome, gastrointestinal symptoms and bleeding due to rupture of abdominal 
lymph nodes [29]. Thus lysozyme amyloidosis should be considered in cases of 
systemic amyloidosis with renal and gastrointestinal manifestations.  
Lysozyme has been chosen as a working protein to look for the conformational variants 
formed under various  conditions  due  to  various  reasons  like  lysozyme  is  a  small  
ubiquitous  protein and has been shown to form amyloid in vitro under various 
conditions. It is well characterized and its activity can be checked using Micrococcus 
lysodeiktikus bacterial cells. The enzymatic activity of lysozyme is a good tool to 
estimate the population of monomers and to check for the functionality once lysozyme 
is converted to amyloid. Natural mutants of human lysozyme lead to amyloidosis in 
humans affecting various organs. HEWL which shares good identity with human 
lysozyme has also been shown to form amyloid in vitro under certain destabilizing 
conditions. The enormous information available on lysozyme along with the various 
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conditions that have been successful in the aggregation of lysozyme in vitro makes 
lysozyme an ideal model for the study of amyloidosis. 
 
1.8. BACKGROUND 
From the initial observation of variants in amyloid formed from a single polypeptide 
there is similar possibilities of variants in other amyloid fibers and the consequence of 
these variants are now emerging as an important area of research. Different families 
suffering from lysozyme amyloidosis have resulted in different symptoms such as renal 
manifestations with sicca syndrome, gastrointestinal symptoms, and intense bleeding 
due to rupture of abdominal lymph nodes. This might be due to variants of human 
lysozyme carrying different mutations and thus showing different phenotype.   Mark B. 
Pepys and his colleagues found that two families having similar gene mutation 
(Asp67His) were showing different phenotypes of lysozyme amyloidosis [33]. The 
reason for distinct phenotype is unknown however one possible reason could be 
different conformations of lysozyme amyloid. 
 Thus different conformations of lysozyme amyloid formed can be correlated with 
different phenotypes of lysozyme amyloidosis and also with previous studies on A-beta 
amyloid. Whether subtle changes could lead to changes in the rate of amyloid 
formation and conformation of aggregation will also be determined.  With  the  two  
well-known  natural  mutants  I56T  and  D67H  of  human lysozyme few more natural 
mutants have been discovered which cause lysozyme amyloidosis. They are F57I, 
W64R, T70N, W112R/T70N.  The mutants can be analyzed for their conformational 
variants and thus correlating with different phenotype of lysozyme amyloidosis. 
  
Figure 1.7: Different amyloid conformations expected to form under static and agitated conditions 
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MATERIALS AND METHODS  
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2.1. FORMATION OF HEN EGG WHITE LYSOZYME (HEWL) AMYLOID 
AGGREGATES 
Amyloid aggregates were prepared at pH 2.0 by dissolving HEWL (Sigma, CAT no. 
L6876) in 0.5 M Glycine HCl buffer at a concentration of 1mM and incubating the 
solution at 37°C for 7 days [34]. Amyloid under different fibrillization conditions was 
formed by keeping agitation under one case and non-agitated in the other case. Non-
agitated amyloid fibrils were formed at 37°C in the incubator whereas the agitated 
amyloid was formed in Spectra max M5e reader with agitation of 30 seconds after 
every 3 minutes.  
Fibrillization buffer: Glycine-HCl buffer – 0.5 M 
Working protein: HEWL – 1mM, Molecular weight – 14307 KDa, Amount of 
lysozyme weighed – 14.307 mg. Weighed amount was dissolved in Glycine – HCl 
buffer such that the final volume becomes 1ml. 
2.2. CONFIRMATORY ASSAYS FOR AMYLOIDS AGGREGATES 
 
2.2.1. Thioflavin – T (ThT) binding assay 
Method: Thioflavin T (ThT) is a fluorescent dye and is used as a “gold standard” for 
selectively identifying the amyloid fibrils in vitro. ThT binding assay is more a 
sensitive and convenient technique. The dye selectively binds to amyloid fibrils 
subsequently showing a dramatic increase in fluorescent brightness [35]. LeVine 
initially characterized the binding property of ThT to amyloid fibrils. ThT associates 
rapidly with aggregated fibril giving rise to a new excitation maximum at 450 nm and 
enhanced emission at 482 nm, as opposed to the 385 nm (ex) and 445 nm (em) of the 
free dye [36]. ThT binds to diverse amyloid fibrils composed of different amino acid 
sequences. Since all amyloid fibrils contains a common cross beta core structure, it is 
largely believed that surface of cross-beta forms binding sites for ThT. Khurana et al. 
hypothesized that hydrophobic interactions exists between the amyloid and ThT 
micelles resulting in enhanced emission fluorescence [37]. 
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    Figure 2.1: Structure of Thioflavin T 
For testing the presence of lysozyme amyloid fibrils, an aliquote of 75 µl each from 
agitated and non-agitated samples incubated at 37°C for 7 days were mixed with 5 µl of 
30 mM stock ThT. The mixture was stirred for one min in the 96- well microplate in 
the dark, after which the fluorescence was measured. A baseline measurement of just 
the ThT with fibrillization buffer was also taken. The fluorescence end point was 
recorded by excitation at 450 nm and observing the emission at 485 nm on a 
SpectraMax M5e fluorimeter.  Excitation and emission spectra were also recorded.  
For excitation spectra, emission was fixed at 485 nm and excitation spectra were 
scanned from 250 nm – 470 nm. For emission spectra, excitation was fixed at 450 nm 
and emission spectra were scanned from 460 nm – 560 nm. 
Thioflavin - T stock: Initially a stock of ThT was made by dissolving 10 mg of ThT in 
200 µl of dimethyl sulfoxide (DMSO). From this stock, 40 µl was taken and dissolved 
in 160 µl of distilled water to get a final concentration of 30mM. 
2.2.2 Congo red (CR) binding assay 
Congo red is a linear dye molecule and it is suggested that CR binds to amyloid by 
hydrogen bonds (amino group of congo red and hydroxyl groups of amyloid) and is 
simultaneously trapped in channels of beta pleated sheets by non-specific forces [38]. 
The binding of Congo red to amyloid induces a characteristic red shift in the maximal 
optical absorbance of the molecule from 490 nm to 540 nm. Congo red binding has 
been assumed to depend on the secondary, β-pleated configuration of the fibril, 
possibly mediated by hydrophobic interactions of the benzidine centers as well as the 
electrostatically charged terminal groups. 
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Figure 2.2: Structure of Congo red 
For Congo red binding assay, a fresh stock solution of Congo red (from Himedia, CAT 
no. RM508) was prepared in phosphate buffered saline from sigma (PBS buffer, pH 
7.4: NaCl – 0.137M, KCl – 2.7 Mm, KH2PO4 – 1.5 mM, Na2HPO4 – 8.1 mM) with 
10% ethanol to avoid micelle formation. The lysozyme amyloid sample of 1mM was 
diluted three times to get a final concentration of 0.33 mM (330 µM). To this, Congo 
red was added from the stock to get the final concentration of 32 µM thus bringing the 
protein to CR ratio nearly 10: 1. Spectrophotometric analysis of CR-lysozyme amyloid 
binding was performed using Spectra max M5e spectrofluorimeter. Absorption 
spectrum was recorded from 300 nm to 700 nm range.  CR-Lysozyme amyloid mixture 
was incubated for thirty minutes before spectral analysis. 
Congo red stock: A stock of 10 mM of Congo red was prepared in PBS buffer with 10 
% to avoid micelle formation. From the above stock another stock of 100 µM was 
prepared to use in the assay. 
2.3. MEASUREMENT OF TURBIDITY BY LIGHT SCATTERING 
After confirming that the aggregates formed are amyloid like aggregates but not 
amorphous aggregates, light scattering assay was performed to throw light on the size 
of the particles. Particles present in solution scatter the incident light and fluctuations in 
the scattered light intensity is based on particle size. Light scattering was measured at 
both excitation and emission wavelength of 450 nm. This kind of scattering is called as 
Rayleigh scattering. The higher order amyloid aggregates are expected to show more 
scattering than the soluble protein. 
In a 96 well-plate, an aliquot of 100 µl from 1mM solution of soluble lysozyme and 
amyloid fibrils formed under agitated and non-agitated conditions were taken. The 
samples incubated along with ThT were used in this assay to measure the scattering. 
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The light scattering was measured by setting both the excitation and emission 
wavelength to 450 nm in spectra max spectrofluorimeter. Scattering of respective 
blanks were also measured. 
 
2.4 ANALYSIS OF HYDROPHOBIC REGIONS OF HEWL AMYLOID FORMED     
UNDER STATIC VS AGITATED CONDITIONS  
The structural characteristics of the aggregates can also be classified using fluorescent 
dye 1-anilinonaphthalene-8-sulfonate (ANS). Fluorescence spectroscopy is an attractive 
method for studies, due to sensitivity, ease of use, and flexibility. ANS is non-
fluorescent in water (polar environment) but is highly fluorescent in hydrophobic 
environments. ANS binding with proteins is associated with two simultaneous events 
i.e. increase in fluorescence intensity and a blue shift of ANS fluorescence.  
ANS is sulfonated naphthalene with Aniline group (figure 2.3). The naphthalene 
backbone and the aniline group are hydrophobic, but sulfonate group has negative 
charge. Amide at the aniline ring can provide electrons for hydrogen bond formation 
with a protein. Using sulfonate group ANS can interact with positively charged amino 
acids. 
ANS is widely used to measure exposed hydrophobic patches on proteins, and presence 
of exposed hydrophobic patches is a common feature of highly toxic soluble 
aggregates.  
 
Figure 2.3: Structure of ANS, 1-anilinonaphthalene-8-sulfonate 
Aliquots of protein solutions after incubation for at 37 degree Celsius to form amyloids 
were taken and diluted to give a 50 µM concentration in 200 mM ANS. Spectra max 
was used to record fluorescence spectra between 400 and 600 nm upon excitation of the 
sample at 380 nm. 
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2.5. PROBING THE ACCESSIBILITY OF TRYPTOPHAN IN SOLUBLE PROTEIN 
VS AMYLOID AGGREGATES 
HEWL has six tryptophan (Trp) residues, Trp 28, 62, 63, 108, 111, 123. Among these 
residues, Trp 62, Trp 63 and Trp 123 are solvent accessible. The fluorescence emission 
of tryptophan undergoes a blue shift when the polarity of its environment decreases. 
Intrinsic tryptophan fluorescence can be a useful probe for the characterization of 
aggregates formed.  
The intrinsic fluorescence spectra of Trp were measured on fluorescence 
spectrophotometer (spectra max M5e) with a cuvette of 1cm path length at room 
temperature. The concentration of HEWL protein samples were initially determined by 
using the absorbance value at 280nm. The molar extinction coefficient of lysozyme is 
2.56 M
-1
 CM
-1. 
 For Trp emission spectra, the excitation wavelength was at 295 nm and 
the emission spectra were recorded in the wavelength range of 300 – 400 nm.  
Acrylamide Quenching: 
Fluorescence quenching is a process which decreases the intensity of the fluorescence 
emission. The accessibility of Trp group on monomeric lysozyme and amyloidogenic 
form can be measured by use of quenchers. Quenching by acrylamide occurs by 
collisional mechanism. Here the quencher, acrylamide deactivates the excited state and 
since collisional or dynamic quenching depopulates the excited state without allowing 
fluorescence emission, the fluorescence intensity decreases.  
Acrylamide quenching of Trp fluorescence was carried out by measurement of 
fluorescence intensity before and after addition of small aliquots of freshly prepared 
acrylamide solution (x M). The assay was performed on both agitated, non-agitated and 
the monomeric lysozyme. The Trp fluorescence intensity was recoded before and after 
adding the acrylamide quencher. The mixture was incubated for 5 minutes in the dark. 
The emission spectrum was scanned from 300-400 nm by setting the excitation 
wavelength to 295 nm.  
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2.6. SELF-SEEDING OF SOLUBLE LYSOZYME BY PREFORMED FIBRILS 
Amyloids exhibit a key phenomenon known as seeding i.e. the rate of formation of 
fibrils by amyloidogenic protein increases by the addition of preformed fibrils [12]. The 
seeds act as a starting material or template for the assembly and growth of amyloid 
fibers. This also acts as a basis for the spread of amyloid deposits in tissues and from 
one organ to another in case of systemic amyloidosis. The growth of amyloid shows 
sigmoidal growth curve with three phases: 
a) Initial lag phase, during which oligomer protein “seed” or nucleus is formed 
b) In the log phase also called as exponential phase or polymerization phase, seeds 
recruit the monomeric protein molecules in exponential manner.   
c) In the last phase called the stationary phase, amyloid is formed completely with 
no further increase in fibrillization process.  
 
Figure 2.4: Growth of amyloid fibrils shows sigmoidal growth curve 
The molecular organization of amyloid fibrils is generally same since all the amyloid 
fibrils contains monomers packed in cross-beta fashion. Nevertheless fibril formation is 
specific, with subtle differences in the interaction between the beta strands making 
seeding specific. Seeding affects the kinetics by decreasing the lag phase and thus over 
all time to form the amyloid.  
Sonication: High frequency sound waves are generated for the disassembly of large 
amyloid polymers to small oligomer seeds with suitable for growth of amyloid. It is the 
ultrasound (amplitude 20%) that is applied to the amyloid samples. Using 70% ethanol 
the probe was first cleaned and then the microcentrifuge tube containing 100 µl of 
amyloid sample was sonicated three times for 10 seconds each on ice. Since some heat 
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may generate during the sonication process, it was preferred to wait for 5 seconds 
between each cycle. 
 The high frequency is generated electronically and the mechanical energy is 
transmitted to the sample via a metal probe that oscillates with high frequency thus 
breaking the amyloid fibrils into smaller seeds with suitable ends for the growth of 
amyloid.  
Seeding kinetics: To outline the seeding conditions, 5 µl of sonicated solution of 
preformed HEWL fibrils was added to 95 µl of fresh solution of the protein made in 
glycine – HCl buffer, pH 2.0, with 5 µl of ThT in 96-well plate to observe the kinetics 
with increase in thioflavin T fluorescence. Seeding kinetics was observed using spectra 
max fluorimeter. The experiment was set for 99 hours to record the ThT emission 
intensity with excitation at 450 nm and emission at 485 nm at an interval of 3 minutes. 
 
 
 
           
           
           
           
           
           
           
           
           
           
  
 
 
Figure 2.5: Procedure for studying seeding kinetics of HEWL 
 
Preformed HEWL amyloid 
solution, at 37 °C, pH 2.0 
Bigger aggregates 
disassemble into smaller 
oligomeric “seeds" 
Sonication 
Addition of 5 % seed to 
fresh solution of lysozyme in 
glycine HCl buffer pH 2.0 
Seeding kinetics recoded for 
99 hours in spectra max 
M5e microplate reader 
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2.7. STABILITY OF LYSOZYME AMYLOID TOWARDS DETERGENT 
Soluble proteins generally dissolve in detergents like SDS and N-Lauroylsarcosine 
sodium salt whereas the amyloid like aggregates can survive these conditions.  Stability 
against detergents is one of the key features of amyloid where the bulky aggregates 
disassemble on treatment with detergents into smaller aggregates, yet partially stable. 
For assessing the sarkosyl stability of the lysozyme amyloid aggregates at room 
temperature a method called Semi Denaturing Detergent Agarose Gel Electrophoresis 
(SDD-AGE) was used.  This method was described by Kryndushkin et al. in the year 
2003 [39]. 
Since the aggregates are bigger in size they cannot be analyzed in polyacrylamide gel 
which has small pores. The pore size is not sufficient for the passage and resolution of 
amyloid like aggregates thus agarose gel was used for running the large protein 
polymers. Kryndushkin DS, et al., (2003) suggested the separation of yeast prion 
[PSI+] in agarose gel followed by western blotting on nitrocellulose membrane to 
observe the size of SDS-resistant amyloid aggregates of yeast prion [PSI+] [39]. 
 SDD-AGE is short form of Semi Denaturing Detergent Agarose Gel 
Electrophoresis. This method enables the characterization of large protein polymers 
which are stable in SDS or Sarkosyl at room temperature. Amyloid fibrils are insoluble 
and thus difficult to study. However they can be resolved based on their size and 
detergent insolubility using the method SDD-AGE. The conformational variants can be 
characterized for their difference in stability against detergents and size using this 
technique. The process involves the following four steps: 
 
1. Preparation of the agarose gel 
2. Preparation of HEWL samples 
3. Agarose gel electrophoresis 
4. Transfer to Polyvinylidene difluoride (PVDF) membrane 
5. Detection of protein on PVDF membrane 
 
Buffers and reagents: Buffer for making agarose gel (1.5%): Tris = 20mM, Glycine = 
200mM, Agarose = 1.5%, SDS = 0.1%; Sample buffer (4x) without SDS and DTT: Tris 
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= 240mM, Bromophenol blue = 0.2%, Glycerol = 2.0%; Electrophoresis running 
buffer: Tris = 20mM, Glycine = 200mM, SDS = 0.1%; Transfer buffer: Tris = 20mM, 
Glycine = 200mM, SDS = 0.1 %, Methanol = 1.5%; Staining solution: coomassie 
brilliant blue R-250 = 0.4 g, methanol = 30%, acetic acid = 10%; Destaining solution: 
Methanol = 30%, acetic acid = 10%. 
Step 1: Preparation of the agarose gel 
a) 1.5% agarose gel was prepared in tris-glycine buffer. The weighed amount of 
agarose was completely dissolved using microwave. 
b) After agarose melted 0.1% SDS was added drop wise from 10% stock with gentle 
swirling to avoid bubble formation. 
c) Agarose solution was then poured into the casting tray enough for submerging the 
comb teeth. 
d) After the gel was set, comb was removed and the gel was placed in the gel tank 
containing the electrophoresis buffer with 0.1% SDS. 
Step 2: Preparation of HWEL samples 
a) To an aliquote of HEWL amyloid fibril, sarcosyl solution was added from 10% 
stock such that the final concentration of sarcosyl becomes 2 %. 
b) The mixture was incubated for 10 minutes to check for the stability of amyloid 
fibrils against the mild detergent sarcosyl. 
Step 3: Agarose gel electrophoresis 
a) From the 4X stock of sample buffer, aliquots were added to the samples to generate 
mixture containing 1X sample duffer.  
b) Samples with 1X sample buffer were incubated at room temperature for 5 minutes 
and were then loaded in gel. 
c) The gel was allowed to run at 125 volts for half an hour.  
Step 4: Transfer to PVDF membrane 
a) A piece of nitrocellulose membrane was cut to the same dimensions as the agarose 
gel. 
b) Two pieces of blotting paper were also cut in same dimensions as gel 
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c) The nitrocellulose membrane was then allowed to soak in distilled water. It should 
be wetted carefully laying it on the surface of water and allowing the nitrocellulose 
membrane to wet from the bottom by capillary action. 
d) After wetting it in distilled water the membrane was submerged in methanol for 1 
minute which acts as activator. 
e) In a plastic container, both the blotting paper and the nitrocellulose membrane were 
then soaked in transfer buffer. 
f) The agarose gel was trimmed and oriented by making a cut in the lower right hand 
corner. 
g) Then each module was assembled in the following order starting from the bottom 
electrode plate (the cathode): First a black foam pad was placed on the bottom of 
electrode plate, then a thick absorbent/blotting paper, thoroughly soaked in transfer 
buffer, a wet nitrocellulose membrane, the agarose gel, a thick absorbent paper, a 
single folded mesh and then the upper electrode (the anode). 
h) While assembling the stack, bubbles were carefully removed by lifting the edges of 
the membrane. 
i) The electrodes were then connected and transfer was allowed to proceed for a 
minimum of 2.5 hours at 100 volts, inside the refrigerator at 4 °C. 
Step 5: Detection of protein on PVDF membrane 
After transfer the membrane was stained with Coommassie R-250 for 5 minutes. 
Membrane was destained overnight with destaining solution and the image was 
captured using gel doc (G:box, syngene). 
 
2.8. STABILITY OF HEWL AMYLOIDS AT PHYSIOLOGICAL pH  
Stability of lysozyme amyloid formed under agitated vs non-agitated condition at pH 
2.0 was checked under physiological pH of 7.4.  Human lysozyme variants are known 
to form amyloid in vivo leading to non-neuropathic amyloidosis. HEWL is known to 
form amyloid in vitro at low pH of 2.0. Thus to check if the HEWL amyloid formed in 
vitro is also stable at physiological pH the following assay was performed.  
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The HEWL is usually fibrillized in glycine – HCl buffer of pH 2.0, 0.5 M. The pH of 
the HEWL amyloid fibril solution was brought to pH 7.4 by mixing it with excess of 
Tris–HCl buffer of pH 7.5, 0.6M.  The details of the assay are tabulated below: 
 
Table 2.1: Preparation of sample mixtures for pH stability assay 
 
2.9. STABILITY OF HEWL AMYLOIDS AGAINST DENATURANTS LIKE UREA 
To further investigate the stability of agitated vs non agitated fibrils, urea induced 
dissociation assay was performed.  Urea is a nonionic chaotropic agent that denatures 
proteins by disrupting the hydrophobic interaction. Denaturants like urea weakens the 
hydrophobic and hydrogen-bonding interactions, thus disrupting aggregation and 
shifting the equilibrium towards monomers. 
Urea was purchased from Sigma Aldrich. 5M stock urea was prepared in 0.5M glycine 
–HCl buffer at pH 2.0. Here we employed ThT fluorescence as a measure to study the 
extent of dissociation in presence of urea. After equilibrating the amyloid fibrils in 
increasing concentration of urea for 30 mins, Thioflavin T was added and fluorescence 
end points were recorded using 96-well plate. The data was then analyzed by plotting 
the fluorescence endpoints against increasing concentrations of urea. 
Samples 
Lysozyme 
amyloid  
Glycine HCl 
buffer pH 2.0, 
0.5 M 
Tris HCl buffer 
pH 7.5, 0.6M 
Glycine HCl 
buffer pH 2.0, 
0.6 M 
Total  
Static amyloid 20 µl  80 µl  100 µl 
Agitated amyloid 20 µl  80 µl  100 µl 
Blank 1  20 µl 80 µl  100 µl 
Blank 2  20 µl  80 µl 100 µl 
Control for Static 
amyloid 
20 µl   80 µl 100 µl 
Control for 
Agitated amyloid 
20 µl   80 µl 100 µl 
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2.10. ENZYME ACTIVITY ASSAY OF SOLUBLE HEWL AND ITS AMYLOID 
FORMS  
10 µl aliquots each of soluble lysozyme dissolved in assay buffer of sodium phosphate 
(100mM, pH 7.4), soluble lysozyme dissolved in fibrillization buffer, and the amyloid 
forms were placed in alternate individual wells of 96-well microplate. A suspension of 
Micrococcus lysodeikticus cells (3 mg) was made in 10 ml of sodium phosphate assay 
buffer shortly before the assay. 190 µl of suspension was added to each well 
containing the lysozyme samples. Cell lysis was monitored at an absorbance of 595 nm 
with intermittent shaking and readings were recorded for a time span of 60 minutes at 
an interval of 30 seconds. The results were then plotted against time in X-axis. 
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CHAPTER III 
RESULTS 
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3.1. CONFIRMATORY ASSAYS FOR HEWL AMYLOID AGGREGATES 
3.1.1. Thioflavin – T (ThT) binding assay 
 
ThT emission fluorescence intensity  was measured after incubating the protein HEWL 
for 7 days at 37 °C, pH 2.0 glycine HCl buffer (Excitation wavelength = 450 nm ; 
Emission wavelength = 485 nm).The samples were incubated with or without agitation 
in the same buffer for the amyloid growth. Increase in ThT fluorescence intensity and 
shift in excitation and emission maxima of ThT fluorescence were observed similar to 
as expected for amyloid aggregates (Table 3.1; Figures 3.1 & 3.2). The higher ThT 
fluorescence intensity observed for aggregates formed under agitated incubation could 
be due to increase in the number of binding sites for ThT and possibly indicate different 
structural organization in these aggregates. 
 
Table 3.1: Thioflavin T fluorescence intensity 
Sample 
 
ThT Fluorescence intensity 
Protein at 4 °C 
Protein at 37 °C  
(non-agitated)  
Protein at 37 °C 
(agitated)  
Blank 107.9 126.9 238.0 
HEWL 272.2 2823.1 4603.7 
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Figure 3.1: Excitation spectrum of HEWL amyloids (a) Static (b) agitated (Emission 
wavelength = 485 nm, Excitation scanned from 250 – 470 nm). The respective blanks 
were subtracted before plotting the data. 
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Figure 3.2: Emission spectrum of HEWL amyloids (a) Static (b) agitated (Excitation 
wavelength = 450 nm, emission spectra scanned from 460 – 560 nm). The respective 
blanks were subtracted before plotting the data. 
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3.1.2. Congo red (CR) binding assay 
Absorption spectrum of Congo red was recorded from 300 – 700 nm after incubating 
the protein-Congo red mixture for 30 minutes. A shift in the absorption peak from 490 
nm to 540 nm in the mixture of lysozyme amyloid and Congo red strongly suggests 
presence of amyloid like structure in the aggregates (Figure 3.3). 
 
 
Figure 3.3: Absorption spectrum of Congo red with HEWL aggregates (a) Static (b) 
Agitated 
 
A 
B 
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3.2 ANALYSIS OF TURBIDITY BY LIGHT SCATTERING 
When amyloid aggregates are formed, the turbidity of the solution increases due to 
accumulation of aggregate particles. Using fluorescence light scattering, we checked if 
the HEWL samples exhibited turbidity. The samples were excited at 450nm and 
emission was measured at same wavelength as an estimate of turbidity. Results showed 
higher scattering in case of HEWL incubated in the fibrillization buffer for 7 days at 37 
°C, pH 2.0 thereby indicating the formation of higher size entity which is consistent 
with amyloid formation (Table 3.2). Possibly, the difference in the extent of light 
scattering of the static vs agitated samples could be a reflection of differences between 
two amyloids with regards to particle size or number of aggregates 
 
Table 3.2: Turbidity measurement of soluble and amyloid forms of HEWL 
Samples 
Fluorescence 
Emission intensity 
(A.U) 
Buffer 4976.9 
Soluble protein 5898.0 
Non-agitated 
amyloid 
11828.5 
Agitated amyloid 7363.0 
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3.3. PROBING THE ACCESSIBILITY OF TRYPTOPHAN IN SOLUBLE PROTEIN 
vs AMYLOID AGGREGATES 
Previously it has been reported that fluorescence of Trp residues in amyloidogenic K 
peptide of HEWL can be quenched by 62% in soluble form and only 41% after 
fibrillization [39]. K-peptide is a small peptide of 8 amino acid residues. Compared to 
the K-peptide, the fluorescence of Trp residues in full length HEWL protein could be 
quenched by 28 % in soluble form and only 23 % in fibrillized form. The peptide with 
random coil structure may have tryptophan more accessible whereas the full length 
protein has tryptophan already inaccessible thus it is showing only marginal differences 
(Table 3.3 & Figure 3.4). The results indicate that HEWL amyloids require more 
acrylamide for quenching of Trp fluorescence suggesting relatively buried Trp residues.  
There was, however, no perceivable difference between the static vs agitated amyloid 
aggregates with regards to the burial of tryptophan residues. 
Table 3.3: Tryptophan fluorescence of HEWL with acrylamide (0.05 M) quencher 
 
Imax  before 
quenching Imax  after quenching 
Percentage 
quenching (%) 
Soluble Protein 3062 2191 28.45 
Static amyloid 3029 2316 23.54 
Agitated amyloid 2702 2073 23.28 
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Figure 3.4: Trp Fluorescence emission spectra with quencher, 0.05M acrylamide. 
3.4. ANALYSIS OF HYDROPHOBIC REGION BY ANS BINDING OF HEWL 
AMYLOID FORMED UNDER STATIC VS AGITATED CONDITIONS 
The fibrillization of HEWL was carried out at acidic pH and elevated temperatures. 
With decrease in pH partial unfolding of a protein may result leading to exposure of 
few hydrophobic regions. ANS, which shows high affinity for hydrophobic patches of 
protein, was found to bind HEWL at pH 2.0 as evident by increased ANS fluorescence 
intensity and blue shift in λmax to ~488 nm from 510 nm (Figure 3.5 & Table 3.4). 
The amyloid forms of HEWL were found to be more amenable to ANS binding 
possibly indicating increase in hydrophobic patches due to conformation change of the 
protein under amyloid forming condition i.e. pH 2.0 and high temperature, 37°C. Static 
amyloid exhibited a little higher ANS binding relative to the agitated amyloid, possibly 
indicating conformational difference between the two amyloids (Table 3.4). 
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 Figure 3.5: Binding of ANS to HEWL amyloids assayed by its extrinsic fluorescence 
(Excitation: 350 nm and Emission: 400-600 nm) 
 Table 3.4: ANS fluorescene upon binding to HEWL amyloid aggregates 
Sample 
ANS Fluorescence Emission 
Imax  (A.U) λmax 
Only ANS 58.14 510 nm 
ANS + Soluble protein pH 7.0 156.22 488 nm 
ANS + Soluble protein pH 2.0 2492.39 486 nm 
Agitated amyloid 3344.86 482 nm 
Static amyloid 3931.07 484 nm 
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3.5. SELF-SEEDING OF SOLUBLE LYSOZYME BY PRE-FORMED FIBRILS 
 
As amyloid aggregates have well organized structure, they show striking ability of 
seeding their un-aggregated counterpart native proteins, thereby converting it also into 
the amyloid form. This process of seeding is highly specific process and depends on the 
conformational compatibility of the amyloid seed and the un-aggregated protein. It is 
known that prion variants are result of amyloid conformational variants, which either 
do not cross-seed or cross-seed each other highly inefficiently. As we succeeded in 
aggregating HEWL under two conditions, we asked if these amyloids have same or 
different conformations by examining whether they can cross-seed each other. First, we 
checked whether these aggregates show self-seeding of the monomeric protein under 
the conditions in which they were previously aggregated.  For this, we examined the: 
 
1. Self-seeding of HEWL incubated under static condition by seed samples pre-
aggregated under static conditions. 
2. Self-seeding of HEWL incubated under agitated condition by seed pre-aggregated 
under agitated conditions. 
 
Next, we checked the conformational cross-seeding ability of these two HEWL 
amyloids by examining: 
1. Cross-seeding of HEWL incubated under agitated condition by  seed pre-
aggregated under static conditions 
2. Cross-seeding of HEWL incubated under static condition by seed samples pre-
aggregated under agitated conditions 
 
The experimental design to check the above mentioned seeding abilities and the 
outcome has been schematically summarized in Figure 3.6. 
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Figure 3.6: Schematic assay of ability of self-seeding and conformational cross-seeding by 
HEWL amyloid aggregates and results obtained. 
 
 
 
HEWL amyloid formed at 37 °C,  
pH 2.0, WITHOUT agitation 
 
HEWL amyloid formed at 37 °C,  
pH 2.0, WITH agitation 
 
Sonication Sonication 
Amyloid Seeds generated 
 
Amyloid Seeds generated 
 
Seeding of HEWL 
WITHOUT agitation 
Seeding of HEWL 
WITH agitation 
Self-seeding 
Conformational 
cross-seeding 
 
Self-seeding 
Conformational 
cross-seeding 
Seeding of HEWL 
WITH agitation 
Seeding of HEWL 
WITH OUT agitation 
Result:               
Self-seeding 
observed       
(Figure 3.7) 
Result:                             
No cross-seeding 
observed                 
(Figure 3.9) 
Result:                           
Self-seeding         
observed                 
(Figure 3.8) 
 
Result:                           
No cross-seeding 
observed               
(Figure 3.10) 
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Figure 3.7: Self-Seeding kinetics of static HEWL with 5% static seeds, self-seeding. 
The protein entered log phase immediately with reduced lag time. The amyloid was 
formed in 49 hours in seeded conditions whereas it takes 168 hours to form amyloid 
without seeding.  
 
Figure 3.8: Seeding kinetics of agitated samples HEWL with agitated seeds (self-
seeding).  
Detectors saturation point reached: Shows high fluorescence intensity of amyloid. A 
strong hint of seeding was observed in this case with very high and increased 
fluorescence intensity in case of seeded protein within an hour. The results from self-
seeding of HEWL confirm the amyloid formation as seen in other amyloids. 
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Figure 3.9: Conformational cross-seeding kinetics of agitated HEWL with static seeds.                   
The agitation reduces the time required for the amyloid formation. Seeds from static 
samples could not show any effective seeding even with 5% seed, suggesting 
conformational variation between the two amyloids. 
 
Figure 3.10: Conformational cross-seeding kinetics of static HEWL samples with 
agitated seeds 
Apparently, the seeds from agitated samples could not seed the protein under static 
conditions further suggesting conformational variation between the two amyloids. 
Very slow growth of amyloid was observed both in case of seeded and unseeded 
samples under static conditions. 
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3.6. ANALYSIS OF RELATIVE STABILITY OF STATIC VS AGITATED HEWL 
AMYLOID AGGREGATES 
If the HEWL amyloid aggregates formed under different conditions (here agitated & 
static) represent variant conformations, they may be expected to have different 
stabilities. To examine this, we assayed the relative stabilities of the static versus 
agitated condition made aggregates against the detergent sarkosyl, pH change and the 
denaturant urea. Indeed we found that, while both aggregates are stable to complete dis-
aggregation by Sarkosyl, they also exhibit different range of sizes of 
oligomers/polymers (Figure 3.11). The HEWL aggregates formed at static incubation 
showed higher size sarkosyl-resistant polymers as compared with the agitated 
aggregates. 
 
 
Figure 3.11: Analysis of sarkosyl resistance of static and agitated HEWL amyloid 
aggregates by SDD-AGE. For this the samples were incubated with sample buffer 
containing 1% sarkosyl at room temperature for 10 minutes and then electrophoresed 
on 1.5% agarose followed by electroblotting on PVDF membrane. Finally, protein was 
visualized by Coommassie staining. 
 
 
66 KDa 
14 KDa 
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Using the relative mobility (Table 3.5) of three proteins of known molecular weights 
(Lysozyme, BSA & HSA homo-dimer), a calibration curve (Figure 3.12) was 
generated which helped in the estimation of molecular weight of the sarkosyl-resistant 
polymers from the HEWL amyloid aggregate formed by agitation or under static 
incubation. From this, the molecular weight of the biggest sarkosyl-resistant polymer in 
static lysozyme amyloid was estimated to be~ 4671 KDa which would contain over 330 
monomers of HEWL. In comparison, the molecular weight of the biggest sarkosyl-
resistant polymer in agitated lysozyme amyloid was estimated to be 864.56 KDa (~ 60 
monomers) suggesting that either the agitated amyloid aggregates are smaller in size in 
general or they are more fragile susceptible to sarkosyl dis-aggregation relative to the 
static amyloid.  This strongly suggests that the two forms of the HEWL amyloid are 
indeed amyloid variants. Similar detergent-resistant size differences have been 
previously observed for yeast [PSI+] prion where the strong variant of [PSI+] shows 
shorter aggregates of Sup35 amyloid relative to the weak variant of [PSI+] [40]. 
 
Table 3.5: Relative mobility of protein samples and HEWL amyloids on SDD-AGE 
Protein sample 
Distance moved 
in cm [X] 
Gel front in cm 
[Y] 
Relative 
mobility 
[X/Y] 
Lysozyme (14 Kda) 5.0 5.5 0.909 
BSA (66KDa) 4.2 5.5 0.7636 
HSA dimer (134KDa) 3.8 5.5 0.69 
Lysozyme amyloid (Static)   1.9 5.5 0.3454 
Lysozyme amyloid (agitated)   2.8 5.5 
0.509 
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Figure 3.12:   
We further tested the stabilities of the two types of amyloid aggregates against change 
in pH by measuring ThT fluorescence emission and excitation intensities (Figure 3.13). 
First the aggregates pre-made in the fibrillization buffer pH 2.0 were shifted to pH 7.0 
and allowed to equilibrate. Subsequently ThT emission and excitation intensities at 
485nm and 450 nm were recorded as described in the methods. While the aggregates 
formed by agitation showed partial dis-aggregation by this pH change, the aggregates 
made under static conditions were remarkably stable to this pH change (Figure 3.13 & 
Figure 3.14).  This observation further supports variant amyloid conformation in the 
two types of aggregates. 
 
Figure 3.13: Comparison of HEWL amyloids stability at pH 2.0 vs pH 7.0 
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Figure 3.14: ThT excitation and emission spectra of HEWL amyloid aggregates at pH 
2.0 & 7.0 
 
Furthermore, we examined the dis-aggregation of the two types of amyloid aggregates 
by the potent chaotroph urea which is well known to denature proteins by breaking 
hydrophobic interactions. Consistent with the pH dis-aggregation data, the static 
amyloid aggregates showed greater urea stability as well, as compared with the agitated 
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amyloid aggregates (Figure 3.15). This further indicates that the conformations of the 
two amyloids are different. 
 
 
Figure 3.15: Stability of amyloids towards increasing concentration of denaturant urea  
 
3.7. ENZYME ACTIVITY ASSAY OF SOLUBLE HEWL AND ITS AMYLOID 
FORMS 
When the agitated and static amyloids pre-fibrillized at pH 2.0 are shifted to pH 7.0 for 
lysozyme activity, only the agitated aggregates regain lysozyme activity which could be 
either because of release of monomers from the aggregates or due to presence of 
monomers in the fibrillized samples if  all protein monomers had not joined the 
aggregates (Figure 3.16). However, the possibility that the lysozyme molecules even 
after joining the aggregates formed by agitation (which are relatively short size 
aggregates) may retain the activity cannot be ruled out. 
 
Figure 3.16: Enzyme activity kinetics of soluble HEWL and amyloid forms 
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CHAPTER IV 
CONCLUSION 
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Conclusion  
Hen Egg White Lysozyme is a good model protein, being easily available and is well 
characterized, both enzymatically and structurally. The results can be correlated to in 
vivo lysozyme amyloidosis since HEWL shows 60% sequence identity with human 
lysozyme and it also displays a large degree of structural homology with human 
lysozyme.  
From the Thioflavin T fluorescence and Congo red binding assays it is clear that 
HEWL can be induced to form amyloid at low pH of 2.0 and at 37 °C. Kinetic results 
show that the presence of agitation increases the rate of formation of amyloid. 
Analysis of seeding and conformational cross seeding indicates the formation of 
conformational variants in the presence and absence of agitation during fibrillization. 
While the self-seeding was efficient when the static amyloid seeds were used to seed 
static incubated monomers (or if the agitated amyloid seeds were used to seed the 
agitated monomers), the cross-seeding of agitated monomers by static amyloid seed (or 
the cross-seeding of static monomers by agitated amyloid seed) was not observed 
(Figure 3.7-3.10). The presence of variant conformation is further and strongly 
supported by the observation that the two types of amyloids show different sizes of 
detergent (sarkosyl)-resistant particles and also exhibit different stabilities against pH 
and urea. Taken together, here we succeeded in generating self-propagating amyloid 
variants of HEWL amyloid aggregates, a finding that could have relevance to the 
human lysozyme amyloidosis. 
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Figure 3.17: Summary of observations on seeding & conformational cross-
seeding of HEWL amyloid aggregates 
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